Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants

NCT04454918 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-906 Oral Capsule
DRUG: [14C]-TAK-906 Intravenous Infusion
DRUG: [14C]-TAK-906 Oral Solution

Sponsor

Millennium Pharmaceuticals, Inc.